for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Helix Biopharma Reports Q2 Loss Per Share of C$0.03

March 19 (Reuters) - Helix Biopharma Corp:

* . ANNOUNCES FISCAL SECOND QUARTER 2018 RESULTS

* Q2 LOSS PER SHARE C$0.03 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up